Chuck Royce acquired 1.12 Million Core Laboratories shares worth $20.1 Million. That's 0.18% of their equity portfolio (162nd largest holding). The investor owns 2.40% of the outstanding Core Laboratories stock. The first Core Laboratories trade was made in Q1 2013. Since then Chuck Royce bought shares seven more times and sold shares on eight occasions. The investor's estimated purchase price is $21.4 Million, resulting in a loss of 6.2%.